INVESTORS & MEDIA
News Release
Regeneron Announces Upcoming 2013 Investor Conference Presentations
- Morgan Stanley Global Healthcare Conference on Monday, September 9, 2013. The presentation is scheduled for 2:25 p.m. Eastern Time.
- Baird's 2013 Healthcare Conference on Tuesday, September 10, 2013. The presentation is scheduled for 1:10 p.m. Eastern Time.
The presentations may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
Contact Information:
Manisha Narasimhan, Ph.D.
Investor Relations
914.847.5126
manisha.narasimhan@regeneron.com
Peter Dworkin
Corporate Communications
914.847.7640
peter.dworkin@regeneron.com